SCHEMBL5649485

SCHEMBL5649485

CN(C(=O)On1nccc1-c1cccs1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
USP2 O75604 1/20 0.43
PIM1 P11309 2/20 0.40
PIM3 Q86V86 1/20 0.40
PLK3 Q9H4B4 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
KDM4E B2RXH2 4/20 0.38
KMT2A Q03164 4/20 0.38
NTRK1 P04629 2/20 0.37
AURKA O14965 1/20 0.37
JAK2 O60674 1/20 0.37
RET P07949 1/20 0.37
FGFR1 P11362 1/20 0.37
PRKACA P17612 1/20 0.37
LTK P29376 1/20 0.37
KDR P35968 1/20 0.37
MAP2K2 P36507 1/20 0.37
FLT3 P36888 1/20 0.37
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5651462 0.78 KDM5A (0.45) ALDH1A1KDM4EKMT2ALMNAL3MBTL1
SCHEMBL5648790 0.77 GPBAR1 (0.37) ALDH1A1KDM4EKMT2ALMNAL3MBTL1
SCHEMBL5649808 0.77 L3MBTL1 (0.42) ALDH1A1KDM4EKMT2ALMNAL3MBTL1
SCHEMBL6628903 0.77 PIM1 (0.49) ALDH1A1PIM1PIM3PLK3PIM2
SCHEMBL5648630 0.76 LIPE (0.47) ALDH1A1KDM4EKMT2ALMNAL3MBTL1
SCHEMBL5651017 0.76 L3MBTL1 (0.41) ALDH1A1KDM4EKMT2ALMNAL3MBTL1
SCHEMBL5647593 0.76 LMNA (0.43) ALDH1A1KDM4EKMT2ALMNAL3MBTL1
SCHEMBL5649524 0.76 L3MBTL1 (0.41) ALDH1A1KDM4EKMT2ALMNAL3MBTL1
SCHEMBL5645411 0.75 ALDH1A1 (0.44) ALDH1A1USP2KDM4EKMT2ALMNA
SCHEMBL5650139 0.75 ALDH1A1 (0.47) ALDH1A1USP2KDM4EKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1602191-A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK AS (DK) 2005-03-30 CN claimed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP claimed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US claimed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO claimed
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
CN-1326519-C Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK AS (DK) 2007-07-18 CN disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
CN-1602191-A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK AS (DK) 2005-03-30 CN disclosed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
EP-1458375-A2 COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051842-A2 COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL ALDH1A1 1304/4885USP2 569/4885PIM1 3801/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL ALDH1A1 1599/4885USP2 434/4885PIM1 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.